News
Intracellular protein trafficking and secretion of proteins into the extracellular environment are sequential and tightly regulated processes in ...
To the dread of dietitians across the planet, there's an even more extreme version of 'intermittent fasting' being taken up ...
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...
"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...
Biologist and physician Ana María Cuervo and paleoanthropologist Juan Luis Arsuaga reflect on whether age-related decline can ...
16d
News-Medical.Net on MSNPeptide nanostructures block amyloid buildup and boost neuron survival in lab testsResearchers developed trehalose-functionalized peptide amphiphiles (TPAs) that self-assemble into supramolecular ...
Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.
Liver injury remains a critical global health issue as it can lead to severe complications such as fibrosis, cirrhosis, and hepatocellular carcinoma.
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases, today announced an update related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results